Differential Immune-Related Microenvironment Determines Programmed Cell Death Protein-1/Programmed Death-Ligand 1 Blockade Efficacy in Patients With Advanced NSCLC
Masayuki Shirasawa, Tatsuya Yoshida, Yukiko Shimoda, Daisuke Takayanagi, Kouya Shiraishi, Takashi Kubo, Sachiyo Mitani, Yuji Matsumoto, Ken Masuda, Yuki Shinno, Yusuke Okuma, Yasushi Goto, Hidehito Horinouchi, Hitoshi Ichikawa, Takashi Kohno, Noboru Yamamoto, Shingo Matsumoto, Kōichi Goto, Shun‐ichi Watanabe, Yuichiro Ohe, Noriko Motoi
Topics & Concepts
MedicineBlockadeProgrammed cell deathProgrammed cell death 1Ligand (biochemistry)Immune checkpointPD-L1Immune systemCancer researchApoptosisTumor microenvironmentComputational biologyImmunotherapyImmunologyReceptorInternal medicineBiochemistryBiologyCancer Immunotherapy and BiomarkersColorectal and Anal CarcinomasCAR-T cell therapy research